HAIXI PHARMA (02637) Announces Appointment of Liu Guoxian as Joint Company Secretary, Authorized Representative, and Legal Process Agent

Stock News

Mar 06

HAIXI PHARMA (02637) announced that Ms. Lin Huiyi has resigned from her positions as the company's Joint Company Secretary; the authorized representative of the company as stipulated under Rule 3.05 of the Hong Kong Exchanges and Clearing Limited (HKEX) Securities Listing Rules; the authorized representative of the company under Part 16 of the Hong Kong Companies Ordinance (Chapter 622), collectively referred to with the Listing Rules authorized representative as the "Authorized Representative"; and the company's authorized person for receiving legal process documents and notices in Hong Kong as required by Rule 19A.13(2) of the Listing Rules (the Legal Process Agent). These resignations are effective from March 6, 2026. Ms. Zhang Junhuan will remain as one of the Joint Company Secretaries. Mr. Liu Guoxian has been appointed as Joint Company Secretary, Authorized Representative, and Legal Process Agent, effective from March 6, 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1175166735"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1175166735\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1175166735?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-06 16:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1175166735","market":"sh","top_or_hot":-1,"title":"HAIXI PHARMA (02637) Announces Appointment of Liu Guoxian as Joint Company Secretary, Authorized Representative, and Legal Process Agent","media":"Stock News","content":"<p>HAIXI PHARMA (02637) announced that Ms. Lin Huiyi has resigned from her positions as the company's Joint Company Secretary; the authorized representative of the company as stipulated under Rule 3.05 of the Hong Kong Exchanges and Clearing Limited (HKEX) Securities Listing Rules; the authorized representative of the company under Part 16 of the Hong Kong Companies Ordinance (Chapter 622), collectively referred to with the Listing Rules authorized representative as the \"Authorized Representative\"; and the company's authorized person for receiving legal process documents and notices in Hong Kong as required by Rule 19A.13(2) of the Listing Rules (the Legal Process Agent). These resignations are effective from March 6, 2026. Ms. Zhang Junhuan will remain as one of the Joint Company Secretaries. Mr. Liu Guoxian has been appointed as Joint Company Secretary, Authorized Representative, and Legal Process Agent, effective from March 6, 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HAIXI PHARMA (02637) Announces Appointment of Liu Guoxian as Joint Company Secretary, Authorized Representative, and Legal Process Agent</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHAIXI PHARMA (02637) Announces Appointment of Liu Guoxian as Joint Company Secretary, Authorized Representative, and Legal Process Agent\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-03-06 16:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>HAIXI PHARMA (02637) announced that Ms. Lin Huiyi has resigned from her positions as the company's Joint Company Secretary; the authorized representative of the company as stipulated under Rule 3.05 of the Hong Kong Exchanges and Clearing Limited (HKEX) Securities Listing Rules; the authorized representative of the company under Part 16 of the Hong Kong Companies Ordinance (Chapter 622), collectively referred to with the Listing Rules authorized representative as the \"Authorized Representative\"; and the company's authorized person for receiving legal process documents and notices in Hong Kong as required by Rule 19A.13(2) of the Listing Rules (the Legal Process Agent). These resignations are effective from March 6, 2026. Ms. Zhang Junhuan will remain as one of the Joint Company Secretaries. Mr. Liu Guoxian has been appointed as Joint Company Secretary, Authorized Representative, and Legal Process Agent, effective from March 6, 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1191","symbol_name":"制药","start_time":0,"source_url":"","article_id":"1175166735","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1175166735","pubTimestamp":1772786581,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"HAIXI PHARMA (02637) announced that Ms. Lin Huiyi has resigned from her positions as the company's Joint Company Secretary; the authorized representative of the company as stipulated under Rule 3.05...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1191":"制药","02637":"海西新药"},"translate_title":"海西药业(02637)公布委任刘国贤为联席公司秘书、授权代表、法律程序代理人","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02637":1},"content_text":"HAIXI PHARMA (02637) announced that Ms. Lin Huiyi has resigned from her positions as the company's Joint Company Secretary; the authorized representative of the company as stipulated under Rule 3.05 of the Hong Kong Exchanges and Clearing Limited (HKEX) Securities Listing Rules; the authorized representative of the company under Part 16 of the Hong Kong Companies Ordinance (Chapter 622), collectively referred to with the Listing Rules authorized representative as the \"Authorized Representative\"; and the company's authorized person for receiving legal process documents and notices in Hong Kong as required by Rule 19A.13(2) of the Listing Rules (the Legal Process Agent). These resignations are effective from March 6, 2026. Ms. Zhang Junhuan will remain as one of the Joint Company Secretaries. Mr. Liu Guoxian has been appointed as Joint Company Secretary, Authorized Representative, and Legal Process Agent, effective from March 6, 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"executive","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}